Polish biotech outfit teams up with US pharma to produce Covid vaccine

The Novavax vaccine is a traditional vaccine, not based on the mRNA technology with which Pfizer and Moderna were produced, and contains a modified protein fragment of the coronavirus. Mabion press materials

In this episode of The Debrief, we get the inside info from Mabion, a Polish biotech firm which has teamed up with Novavax in the US to produce Covid vaccines.

Production of such a vaccine could be a real boon for the Polish biotech sector, host John Beauchamp hears from Mabion SA board member Adam Pietruszkiewicz in this week’s interview.

In this week’s review: 

Polish MFA monitoring case of Pole doing 14 years in Russian labour camp

Over 70% of Polish are women financially independent 

• Mystery 200-year-old crypt found by builders 

Matejko to be first-ever Polish artist exhibited at London’s National Gallery 

Why not drop me a line? You can get in touch with the show by writing to podcasts@thefirstnews.com, and please remember to share, like and subscribe to The Debrief!